Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer

被引:100
作者
Anthony, T
Simmang, C
Hyman, N
Buie, D
Kim, D
Cataldo, P
Orsay, C
Church, J
Otchy, D
Cohen, J
Perry, WB
Dunn, G
Rafferty, J
Ellis, N
Rakinic, J
Fleshner, P
Stahl, T
Gregorcyk, S
Ternent, C
Kilkenny, JW
Whiteford, M
机构
[1] The Standards Practice Task Force, The American Society of Colon and Rectal Surgeons
关键词
D O I
10.1007/s10350-004-0519-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The American Society of Colon and Rectal Surgeons is dedicated to assuring high quality patient care by advancing the science, prevention, and management of disorders and diseases of the colon, rectum, and anus. The Standards Committee is composed of Society members who are chosen because they have demonstrated expertise in the specialty of colon and rectal surgery. This Committee was created to lead international efforts in defining quality care for conditions related to the colon, rectum, and anus. This is accompanied by developing Clinical Practice Guidelines based on the best available evidence. These guidelines are inclusive, and not prescriptive. Their purpose is to provide information on which decisions can be made, rather that dictate a specific form of treatment. These guidelines are intended for the use of all practitioners, health care workers, and patients who desire information about the management of the conditions addressed by the topics covered in these guidelines. It should be recognized That these guidelines should not be deemed inclusive of all proper methods of care or exclusive of methods of care reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific procedure must be made by the physician in light of all of the circumstances presented by the individual patient.
引用
收藏
页码:807 / 817
页数:11
相关论文
共 57 条
[31]   THE VALUE OF SERUM CARCINOEMBRYONIC ANTIGEN IN PREDICTING RECURRENT DISEASE FOLLOWING CURATIVE RESECTION OF COLORECTAL-CANCER [J].
MCCALL, JL ;
BLACK, RB ;
RICH, CA ;
HARVEY, JR ;
BAKER, RA ;
WATTS, JM ;
TOOULI, J .
DISEASES OF THE COLON & RECTUM, 1994, 37 (09) :875-881
[32]  
McCredie M, 1997, CANCER EPIDEM BIOMAR, V6, P155
[33]  
MINTON JP, 1985, CANCER, V55, P1284, DOI 10.1002/1097-0142(19850315)55:6<1284::AID-CNCR2820550622>3.0.CO
[34]  
2-B
[35]   AN EVALUATION OF THE CARCINOEMBRYONIC ANTIGEN (CEA) TEST FOR MONITORING PATIENTS WITH RESECTED COLON-CANCER [J].
MOERTEL, CG ;
FLEMING, TR ;
MACDONALD, JS ;
HALLER, DG ;
LAURIE, JA ;
TANGEN, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08) :943-947
[36]  
NORTHOVER JMA, 1985, BR J SURG S, V72, P44
[37]   A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer [J].
Norum, J ;
Olsen, JA .
ANNALS OF ONCOLOGY, 1997, 8 (11) :1081-1087
[38]   FOLLOW-UP AFTER CURATIVE SURGERY FOR COLORECTAL-CARCINOMA - RANDOMIZED COMPARISON WITH NO FOLLOW-UP [J].
OHLSSON, B ;
BRELAND, U ;
EKBERG, H ;
GRAFFNER, H ;
TRANBERG, KG .
DISEASES OF THE COLON & RECTUM, 1995, 38 (06) :619-626
[39]  
OHLSSON B, 1993, EUR J SURG, V159, P275
[40]   An evaluation of postoperative follow-up tests in colon cancer patients treated for cure [J].
Peethambaram, P ;
Weiss, M ;
Loprinzi, CL ;
Novotny, P ;
OFallon, JR ;
Erlichman, C ;
OConnell, MJ ;
Laurie, JA .
ONCOLOGY, 1997, 54 (04) :287-292